BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8575837)

  • 21. Cloning and characterization of cDNAs encoding VH and VL of a monoclonal anti-CEA antibody (CEA 79) cross-reactive with NCA-95 and generation of a single-chain Fv molecule (scFv).
    Chung JH; Choi SJ; Kim HJ; Kim IJ; Choi IH; Lee SD; Yi KS; Suh PG; Ryu SH; Chung HK
    Mol Cells; 1997 Dec; 7(6):816-9. PubMed ID: 9509426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.
    Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I
    Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of VH and VL consensus sequence-specific primers on the binding and neutralizing potential of a single-chain FV directed towards HuIFN-gamma.
    Froyen G; Hendrix D; Ronsse I; Fiten P; Martens E; Billiau A
    Mol Immunol; 1995 May; 32(7):515-21. PubMed ID: 7783754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
    Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
    Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cloning, ligation and expression of the variable region genes of the monoclonal antibody against human HnRNPA2/B1].
    Wang X; Peng XD; Li G; Hu LJ; Bi JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):548-51. PubMed ID: 15583979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus.
    Alvi AZ; Stadnyk LL; Nagata LP; Fulton RE; Bader DE; Roehrig JT; Suresh MR
    Hybridoma; 1999 Oct; 18(5):413-21. PubMed ID: 10600028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and purification of a single-chain variable fragment antibody derived from a polyol-responsive monoclonal antibody.
    Lamberski JA; Thompson NE; Burgess RR
    Protein Expr Purif; 2006 May; 47(1):82-92. PubMed ID: 16216525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing.
    Furuta M; Uchikawa M; Ueda Y; Yabe T; Taima T; Tsumoto K; Kojima S; Juji T; Kumagai I
    Protein Eng; 1998 Mar; 11(3):233-41. PubMed ID: 9613848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bacterial single-chain Fv antibody fragment that inhibits binding of its parental anti-E-selectin monoclonal antibody to activated human endothelial cells.
    Casalvilla R; DueƱas M; Ayala M; Cruz S; Cruz L; Buurman WA; Gavilondo JV
    J Biotechnol; 1999 Jun; 72(1-2):1-12. PubMed ID: 10406094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.
    Jain S; Aresu L; Comazzi S; Shi J; Worrall E; Clayton J; Humphries W; Hemmington S; Davis P; Murray E; Limeneh AA; Ball K; Ruckova E; Muller P; Vojtesek B; Fahraeus R; Argyle D; Hupp TR
    PLoS One; 2016; 11(2):e0148366. PubMed ID: 26894679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Production of phage-displayed anti-idiotypic antibody single chain variable fragments to MG7 monoclonal antibody directed against gastric carcinoma].
    He F; Nie Y; Han Z
    Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):33-6. PubMed ID: 11798849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction and secretory expression of single-chain Fv fragment M97 with therapeutic potential against tumor invasion and metastasis].
    Zhou C; Jiang M; Xu L; Zhen Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):81-8. PubMed ID: 11367724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor.
    Tsantili P; Tzartos SJ; Mamalaki A
    J Neuroimmunol; 1999 Feb; 94(1-2):15-27. PubMed ID: 10376932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and immunochemical characteristics of monoclonal and recombinant antibodies selective for the triazine herbicide simetryn and application to environmental analysis.
    Nishi K; Ishiuchi M; Morimune K; Ohkawa H
    J Agric Food Chem; 2005 Jun; 53(13):5096-104. PubMed ID: 15969481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of VL and VH consensus sequence-specific primers on the binding and expression of a mini-molecule antibody directed towards human gastric cancer.
    Li J; Wang Y; Wang Z; Dong Z
    Chin Med Sci J; 2000 Sep; 15(3):133-9. PubMed ID: 12903769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.